Skip to main content
Top
Published in: Clinical & Experimental Metastasis 1/2004

01-01-2004

Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies

Authors: R. Nic Amhlaoibh, P. Hoegh-Andersen, N. Brünner, A. Sørensen, B. Winding, C. Holst-Hansen, M.A. Karsdal, M.T. Engsig, J.M. Delaissé, A.M. Heegaard

Published in: Clinical & Experimental Metastasis | Issue 1/2004

Login to get access
Metadata
Title
Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies
Authors
R. Nic Amhlaoibh
P. Hoegh-Andersen
N. Brünner
A. Sørensen
B. Winding
C. Holst-Hansen
M.A. Karsdal
M.T. Engsig
J.M. Delaissé
A.M. Heegaard
Publication date
01-01-2004
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 1/2004
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/B:CLIN.0000017205.49933.fe

Other articles of this Issue 1/2004

Clinical & Experimental Metastasis 1/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine